DMK Pharmaceuticals Profit Margin

DMK Pharmaceuticals's profit margin stands at -91.28% as of September 2023. That compares with 803.94% in the prior-year period — down 111.4% year over year. That is below the Healthcare sector average of 10.58%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

DMK Pharmaceuticals reported -91.28% in profit margin versus 803.94% a year earlier — a 111.4% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

DMK Pharmaceuticals sits lower the Healthcare benchmark (10.58%) with a profit margin of -91.28%. That is roughly 962.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of -91.28% for DMK Pharmaceuticals means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how DMK Pharmaceuticals's profit margin evolved across reporting periods, while the comparison chart places DMKPQ next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.